Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials

The current meta-analysis was performed to analyze the efficacy and safety of platelet-rich plasma (PRP) as an epidural injectate, in comparison with steroids in the management of radiculopathy due to lumbar disc disease (LDD). We conducted independent and duplicate searches of the electronic databa...

Full description

Saved in:
Bibliographic Details
Main Authors: Sathish Muthu, Vibhu Krishnan Viswanathan, Prakash Gangadaran
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Experimental Biology and Medicine
Subjects:
Online Access:https://www.ebm-journal.org/articles/10.3389/ebm.2025.10390/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542460589375488
author Sathish Muthu
Sathish Muthu
Sathish Muthu
Vibhu Krishnan Viswanathan
Vibhu Krishnan Viswanathan
Prakash Gangadaran
Prakash Gangadaran
Prakash Gangadaran
author_facet Sathish Muthu
Sathish Muthu
Sathish Muthu
Vibhu Krishnan Viswanathan
Vibhu Krishnan Viswanathan
Prakash Gangadaran
Prakash Gangadaran
Prakash Gangadaran
author_sort Sathish Muthu
collection DOAJ
description The current meta-analysis was performed to analyze the efficacy and safety of platelet-rich plasma (PRP) as an epidural injectate, in comparison with steroids in the management of radiculopathy due to lumbar disc disease (LDD). We conducted independent and duplicate searches of the electronic databases (PubMed, Embase and Cochrane Library) in March 2024 to identify randomized controlled trials (RCTs) analyzing the efficacy of epidural PRP for pain relief in the management of LDD. Animal or in vitro studies, clinical studies without a comparator group, and retrospective or non-randomised clinical studies were excluded. Diverse post-intervention pain scores [visual analog score (VAS)] and functional scores [Oswestry Disability Index (ODI), SF-36], as reported in the reviewed studies, were evaluated. Statistical analysis was performed using STATA 17 software. 5 RCTs including 310 patients (PRP/Steroids = 153/157) were included in the analysis. The included studies compared the efficacy and safety of epidural PRP and steroids at various time-points including 1, 3, 6, 12, 24, and 48 weeks. Epidural PRP injection was found to offer comparable pain relief (VAS; WMD = −0.09, 95% CI [−0.66, 0.47], p = 0.641; I2 = 96.72%, p < 0.001), functional improvement (ODI; WMD = 0.72, 95% CI [-6.81, 8.25], p = 0.524; I2 = 98.73%, p < 0.001), and overall health improvement (SF-36; WMD = 1.01, 95% CI [−1.14, 3.17], p = 0.224; I2 = 0.0%, p = 0.36) as epidural steroid injection (ESI) at all the observed time points in the included studies without any increase in adverse events or complications. Epidural administration of PRP offers comparable benefit as epidural steroid injection (ESI) in the management of radiculopathy due to LDD. The safety profile of the epidural PRP is also similar to ESI.
format Article
id doaj-art-96d3fda3129b41cd8f37fc624f742051
institution Kabale University
issn 1535-3699
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Experimental Biology and Medicine
spelling doaj-art-96d3fda3129b41cd8f37fc624f7420512025-02-04T04:11:12ZengFrontiers Media S.A.Experimental Biology and Medicine1535-36992025-02-0125010.3389/ebm.2025.1039010390Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trialsSathish Muthu0Sathish Muthu1Sathish Muthu2Vibhu Krishnan Viswanathan3Vibhu Krishnan Viswanathan4Prakash Gangadaran5Prakash Gangadaran6Prakash Gangadaran7Department of Spine Surgery, Orthopaedic Research Group, Coimbatore, IndiaDepartment of Biotechnology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, IndiaDepartment of Orthopaedics, Government Medical College, Karur, IndiaDepartment of Spine Surgery, Orthopaedic Research Group, Coimbatore, IndiaDepartment of Orthopaedics, Devadoss Hospital, Madurai, IndiaDepartment of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of KoreaBK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, School of Medicine, Kyungpook National University, Daegu, Republic of KoreaCardiovascular Research Institute, Kyungpook National University, Daegu, Republic of KoreaThe current meta-analysis was performed to analyze the efficacy and safety of platelet-rich plasma (PRP) as an epidural injectate, in comparison with steroids in the management of radiculopathy due to lumbar disc disease (LDD). We conducted independent and duplicate searches of the electronic databases (PubMed, Embase and Cochrane Library) in March 2024 to identify randomized controlled trials (RCTs) analyzing the efficacy of epidural PRP for pain relief in the management of LDD. Animal or in vitro studies, clinical studies without a comparator group, and retrospective or non-randomised clinical studies were excluded. Diverse post-intervention pain scores [visual analog score (VAS)] and functional scores [Oswestry Disability Index (ODI), SF-36], as reported in the reviewed studies, were evaluated. Statistical analysis was performed using STATA 17 software. 5 RCTs including 310 patients (PRP/Steroids = 153/157) were included in the analysis. The included studies compared the efficacy and safety of epidural PRP and steroids at various time-points including 1, 3, 6, 12, 24, and 48 weeks. Epidural PRP injection was found to offer comparable pain relief (VAS; WMD = −0.09, 95% CI [−0.66, 0.47], p = 0.641; I2 = 96.72%, p < 0.001), functional improvement (ODI; WMD = 0.72, 95% CI [-6.81, 8.25], p = 0.524; I2 = 98.73%, p < 0.001), and overall health improvement (SF-36; WMD = 1.01, 95% CI [−1.14, 3.17], p = 0.224; I2 = 0.0%, p = 0.36) as epidural steroid injection (ESI) at all the observed time points in the included studies without any increase in adverse events or complications. Epidural administration of PRP offers comparable benefit as epidural steroid injection (ESI) in the management of radiculopathy due to LDD. The safety profile of the epidural PRP is also similar to ESI.https://www.ebm-journal.org/articles/10.3389/ebm.2025.10390/fullPRPepidural steroiddegenerative disc diseasepain reliefbiologics
spellingShingle Sathish Muthu
Sathish Muthu
Sathish Muthu
Vibhu Krishnan Viswanathan
Vibhu Krishnan Viswanathan
Prakash Gangadaran
Prakash Gangadaran
Prakash Gangadaran
Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials
Experimental Biology and Medicine
PRP
epidural steroid
degenerative disc disease
pain relief
biologics
title Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials
title_full Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials
title_fullStr Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials
title_full_unstemmed Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials
title_short Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials
title_sort is platelet rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy meta analysis of randomized controlled trials
topic PRP
epidural steroid
degenerative disc disease
pain relief
biologics
url https://www.ebm-journal.org/articles/10.3389/ebm.2025.10390/full
work_keys_str_mv AT sathishmuthu isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials
AT sathishmuthu isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials
AT sathishmuthu isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials
AT vibhukrishnanviswanathan isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials
AT vibhukrishnanviswanathan isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials
AT prakashgangadaran isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials
AT prakashgangadaran isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials
AT prakashgangadaran isplateletrichplasmabetterthansteroidsasepiduraldrugofchoiceinlumbardiscdiseasewithradiculopathymetaanalysisofrandomizedcontrolledtrials